(1)
Abdul-Aziz, N.; Abdulhameed, N.; Marellapudi, A.; Shah, H. Multiple Sclerosis Anti-CD20 (Ocrelizumab) Therapy Inducing Hypogammaglobulinemia. Translation 2023, 11 (3). https://doi.org/10.46570/utjms.vol11-2023-836.